엠젠솔루션 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 퀀텀딥테크성장투자1호조합, was filed 01 Jul 2026.
엠젠솔루션: what insiders have been doing
엠젠솔루션 is a Health Care company. Its directors and officers file their transactions with DART (FSS). From 1 November 2025 to 1 November 2026, the disclosure feed for 엠젠솔루션 logged 11 filings by 5 insiders.
The record shows 4 purchases on the open market, made by 4 insiders, against 6 sales by 4 insiders. The totals do not cover 10 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 1 major shareholder among the declarants.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 11 filings here. Looking back to 2021, when coverage begins, insiders filed 27 purchases and 9 sales.
The most recent open-market purchase was published on 1 July 2026, 132 days ago. Filings reach the DART (FSS) feed a median of 7 days after the trade. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +14.7%Entry ₩1,020 · Close 30 Oct 2026 ₩1,170
- -33.5%Entry ₩1,760 · Close 30 Oct 2026 ₩1,170
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 7,447,864 sharesKRXDART:20260710000418
- 2,320,740 sharesKRXDART:20260701000658Canonical exit: 29 Sept 2026 (T+90)
- 4,486,307 sharesKRXDART:20260629000552
- 2,793,296 sharesKRXDART:20260508000481
- 2,793,296 sharesKRXDART:20260409003107
- 2,793,296 sharesKRXDART:20260409003075Canonical exit: 2 Jul 2026 (T+90)
- 0KRXDART:20260327001171
- 76,450 sharesKRXDART:20260312000763
- 2,793,296 sharesKRXDART:20260303002247Canonical exit: 24 May 2026 (T+90)
- 16,000 sharesKRXDART:20251231000241
- 7,447,864 sharesKRXDART:20251216000490Canonical exit: 9 Mar 2026 (T+90)
- 3,724,393 sharesKRXDART:20251002000528
- ●Executives0DART
- 80,000 sharesKRXDART:20241226000026
- 2,084,542 sharesKRXDART:20241210000510
- 0KRXDART:20240926000267
- 3,105,189 sharesKRXDART:20240710000795Canonical exit: 17 Sept 2024 (T+90)
- 414,370 sharesKRXDART:20240701000454Canonical exit: 22 Sept 2024 (T+90)
- ShareKRXDART:20240701000495Canonical exit: 21 Mar 2024 (T+90)
- 414,370 sharesKRXDART:20231212000155Canonical exit: 3 Mar 2024 (T+90)
- ShareKRXDART:20231212000156Canonical exit: 21 Sept 2021 (T+90)
25 of 43 declarations
About 엠젠솔루션
엠젠솔루션 is a company listed on the XKRX, specializing in the healthcare and pharmaceutical sector. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
